thymopentin has been researched along with FMR1-Related Primary Ovarian Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, Z; Huang, W; Liu, J; Liu, T; Pan, H; Zhang, B; Zhu, X | 1 |
| Chen, C; Chen, D; Geng, Z; Huang, P; Huang, W; Jing, F; Li, J; Liu, T; Wang, Z; Xu, J; Zhu, Y | 1 |
2 other study(ies) available for thymopentin and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Thymopentin treatment of murine premature ovarian failure via attenuation of immune cell activity and promotion of the BMP4/Smad9 signalling pathway.
Topics: Adjuvants, Immunologic; Animals; Bone Morphogenetic Protein 4; Disease Models, Animal; Female; Mice; Primary Ovarian Insufficiency; Receptor-CD3 Complex, Antigen, T-Cell; Signal Transduction; Smad8 Protein; Thymopentin | 2021 |
Thymopentin alleviates premature ovarian failure in mice by activating YY2/Lin28A and inhibiting the expression of let-7 family microRNAs.
Topics: Animals; Biomarkers; Cell Proliferation; Disease Models, Animal; Exosomes; Female; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; MicroRNAs; Primary Ovarian Insufficiency; Promoter Regions, Genetic; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Signal Transduction; Thymopentin; Transcription Factors | 2021 |